June 13th 2025
Your daily dose of the clinical news you may have missed.
June 3rd 2025
May 28th 2025
GLP-1 receptor agonists showed promise in lowering obesity-related cancer risks in adults with type 2 diabetes, particularly colorectal cancer.
April 24th 2025
New data to be presented at ECO 2025 shows new-onset T2D is linked to increased risk of liver, pancreatic, and bowel cancers, but not endometrial or post-menopausal breast cancer.
July 15th 2024
